Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

2-(15-(4-(3-carboxy-4-(6-hydroxy-3-oxo-3Hxanthen-9-yl)benzamido)butyl)-2-(carboxymethyl)-4,11,14,17-tetraoxo-12-(4-(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)butyl)-3,10,13,16-tetraazadotriacontanamido) pentanedioic acid gadolinium salt nanoparticles

Based on

1 Articles
2015 Most recent source

Composition

1

2-(15-(4-(3-carboxy-4-(6-hydroxy-3-oxo-3Hxanthen-9-yl)benzamido)butyl)-2-(carboxymethyl)-4,11,14,17-tetraoxo-12-(4-(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)butyl)-3,10,13,16-tetraazadotriacontanamido) pentanedioic acid gadolinium salt

Type Single Compound
Formula C80H112GdN11O24
Role raw materials

Properties

General physical and chemical properties

Property Value Source
critical micelle concentration

2 more entries available to subscribers only.

Or, view sample content

Applications

Area Application Source
diagnostics

0 more entry available to subscribers only.

Or, view sample content

Characterization

Method Source
mass spectrometry

1 more entry available to subscribers only.

Or, view sample content

Biological effects

Preparation

Method 1

Type: Chemical synthesis
Source:
  1. UTHlY8nlcrUcdPNXQ
  2. 7bYH
  3. b9kZyLZn
Product

2-(15-(4-(3-carboxy-4-(6-hydroxy-3-oxo-3Hxanthen-9-yl)benzamido)butyl)-2-(carboxymethyl)-4,11,14,17-tetraoxo-12-(4-(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)butyl)-3,10,13,16-tetraazadotriacontanamido) pentanedioic acid gadolinium salt nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial